First Dallas Securities’s Gilead Sciences GILD Stock Holding History

First Dallas Securities’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-3,325	Closed	-$257K	–	99
2018 Q3	$257K	Buy	3,325 +500	+18%	+$37.8K	0.16%	86
2018 Q2	$200K	Sell	2,825 -892	-24%	-$63K	0.13%	100
2018 Q1	$280K	Sell	3,717 -325	-8%	-$25.8K	0.18%	85
2017 Q4	$290K	Sell	4,042 -1,259	-24%	-$95.6K	0.18%	89
2017 Q3	$429K	Sell	5,301 -50	-0.9%	-$3.82K	0.3%	73
2017 Q2	$379K	Sell	5,351 -1,674	-24%	-$111K	0.28%	73
2017 Q1	$477K	Sell	7,025 -325	-4%	-$22.9K	0.33%	64
2016 Q4	$527K	Buy	+7,350	New	+$546K	0.36%	65
2014 Q4	–	Sell	-2,725	Closed	-$290K	–	106
2014 Q3	$290K	Sell	2,725 -806	-23%	-$78.9K	0.17%	83
2014 Q2	$293K	Buy	+3,531	New	+$275K	0.18%	79

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

First Dallas Securities's GILD Position: Q4 2018 in Review

First Dallas Securities sold out of Gilead Sciences (GILD) in Q4 2018, closing a stake of 3,325 shares — an estimated $257K sold.

First Dallas Securities first reported a position in GILD in Q2 2014 and held it in 10 quarters. The position peaked at $527K in Q4 2016. 1,496 funds tracked by Wall St. Rank hold GILD as of Q4 2018.

First Dallas Securities reported no remaining Gilead Sciences position as of Q4 2018 after selling out during the quarter.
First Dallas Securities sold 3,325 Gilead Sciences shares in Q4 2018, an estimated $257K.
First Dallas Securities first reported a position in Gilead Sciences in Q2 2014 and held it in 10 quarters.
First Dallas Securities's Gilead Sciences position peaked at $527K in Q4 2016.
1,496 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2018.

Based on First Dallas Securities's 13F filing for Q4 2018, filed 11 Feb 2019.